Melanoma in situ of right lower limb, including hip
ICD-10 D03.71 is a billable code used to indicate a diagnosis of melanoma in situ of right lower limb, including hip.
Melanoma in situ is a type of skin cancer that is confined to the epidermis, the outermost layer of skin, and has not invaded deeper tissues. The designation 'in situ' indicates that the cancerous cells are localized and have not spread to surrounding tissues or lymph nodes. In the case of D03.71, the melanoma is specifically located on the right lower limb, which includes the thigh, knee, calf, ankle, and foot, as well as the hip region. This condition is characterized by the presence of atypical melanocytes that can be identified through biopsy. Early detection and treatment are crucial, as melanoma in situ has a high cure rate when treated promptly. Surveillance protocols typically involve regular skin examinations and monitoring for any changes in the appearance of the lesion. Patients are advised to practice sun safety and self-examination techniques to detect any new or changing moles. The risk of progression to invasive melanoma is present, particularly if the lesion is not adequately treated, making ongoing surveillance essential.
Detailed descriptions of the lesion, biopsy results, and treatment plans.
Skin examinations, biopsy of suspicious lesions, and follow-up visits for melanoma surveillance.
Ensure accurate documentation of the lesion's size, shape, and color, as well as any changes over time.
Comprehensive treatment plans, including surgical interventions and follow-up care.
Management of melanoma treatment, including surgical excision and monitoring for recurrence.
Document any adjuvant therapies or clinical trials the patient may be involved in.
Used when excising a melanoma in situ from the right lower limb.
Document the size of the lesion and the margins obtained during excision.
Dermatologists should ensure that excision margins are clearly documented.
Coding melanoma as in situ indicates that the cancer is localized and has not invaded deeper tissues, which is crucial for treatment planning and prognosis.
